Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (68)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by STUPPAECK, C. H.
Right arrow Articles by FLEISCHHACKER, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STUPPAECK, C. H.
Right arrow Articles by FLEISCHHACKER, W. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 Medical Council on Alcohol

research-article

CARBAMAZEPINE VERSUS OXAZEPAM IN THE TREATMENT OF ALCOHOL WITHDRAWAL: A DOUBLE-BLIND STUDY

C. H. STUPPAECK, R. PYCHA, C. MILLER, A. B. WHITWORTH, H. OBERBAUER and W. W. FLEISCHHACKER

Department of Psychiatry, Innsbruck University Clinics Anichstr. 35, A-6020 Innsbruck, Austria

Received 12 August 1991; accepted 17 December 1991

The use of more than 130 drugs and drug combinations against the alcohol withdrawal syndrome reflects the fact that views on its treatment are far from being unequivocal. Benzodiazepines are the first choice treatment but it should not be disregarded that they have side effects and, above all, a varying risk of dependency themselves. In recent years many trials have focused on carbamazepine in this respect. Its efficacy was proven in various open and double-blind studies, most of them using concomitant sedative drugs, thereby diminishing the reliability of the results.

In a double-blind study we compared the efficacy of carbamazepine with that of oxazepam, in 60 in-patients suffering from alcohol withdrawal syndrome. The main rating instrument was the Clinical Institute Withdrawal Scale —Alcohol (CIWA-A). The 7-day trial showed equal efficacy of carbamazepine and oxazepam during the first 5 days and a statistically significant superiority of carbamazepine on days 6 and 7. Four patients in each group had to be dropped from the study due to side effects or after having withdrawn informed consent. There was no decrease in white blood counts under carbamazepine. The experiences with carbamazepine up to now suggest a more widespread use, especially in non-delirious withdrawal states.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
V. Prince and K. R. Turpin
Treatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide
Am. J. Health Syst. Pharm., June 1, 2008; 65(11): 1039 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
T. R. Kosten and P. G. O'Connor
Management of Drug and Alcohol Withdrawal
N. Engl. J. Med., May 1, 2003; 348(18): 1786 - 1795.
[Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
T. Wetterling, M. Driessen, R.-D. Kanitz, and K. Junghanns
The severity of alcohol withdrawal is not age dependent
Alcohol Alcohol., January 1, 2001; 36(1): 75 - 78.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. F. Mayo-Smith
Pharmacological Management of Alcohol Withdrawal: A Meta-analysis and Evidence-Based Practice Guideline
JAMA, July 9, 1997; 278(2): 144 - 151.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.